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tinct options toward the long-term goal of the improve-
ment of the quality of patient care.
Clinical investigation research is the discipline by
which physicians and other professionals translate
knowledge gained in basic science to develop both pre-
ventive interventions for diseases and to improve the
outcomes of diseases in patients. With either human
subjects or specimens, this discipline focuses on the
development of new or refined methods of diagnosis
and treatment for patients.1
The discipline of health services research focuses on
efficacy, cost-effectiveness, and outcomes of diagnos-
tic, preventive, interventional, and therapeutic
approaches for patients. Health services research pro-
jects evaluate the delivery, organization, and financing
mechanisms in health care.2 Common study endpoints
for a health services research study include traditional
clinical outcomes (such as mortality or morbidity rates),
health-related quality of life, patient satisfaction, costs
of care, or access to care measures.
I n the field of clinical science, there are several cate-gories of research approaches that may be appropriate
to consider for either a clinical investigation or a health
services research project. Traditionally, research in the
field of medicine has been dedicated to basic science
with a mechanistic focus that uses animal models for
disease. More recently, the fields of clinical investiga-
tion and health services research have emerged as dis-
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CLINICAL SCIENCE RESEARCH
From a study design viewpoint, both the clinical
investigation and health services research categories for
clinical science research design approaches include (but
are not limited to) (1) traditional scientific experiments,
(2) quasi-experimental approaches, and (3) observation-
al clinical outcome studies. These clinical science
research studies can be designed as either retrospective
reviews or prospective studies. The sampling method
selected may be randomized or nonrandomized.
Moreover, the study design may be either blinded or
double-blinded. Finally, either a single-institutional or
multi-institutional approach may be taken. In summary,
the methodologic approaches used for clinical science
research projects are nearly as diverse as the research
questions addressed. Thus the purpose of this article is
to review several common terminology and method-
ologic approaches used as well as to raise the awareness
of clinicians in the pursuit of these types of approaches
for important clinical science research questions.
One of the advantages of clinical science research is
that it offers an opportunity to study clinical questions
in an organized fashion in “real life” situations. It does
not require the expenses of a basic research laboratory
and basic science technology, and it can be performed
as part of academic or private practice. In addition,
clinical science research cannot be criticized because of
species differences, because it only relates to human
subjects. It can be performed relatively economically,
and it can be very practical and answer important
everyday clinical questions related to patient care, prac-
tice management, or health policy.
Overview of the research process
The framework for scientific inquiry generally
involves the evolution from theory to reality. Although
research projects may either be deductive (hypothesis
testing) or inductive (hypothesis generating) in nature,
clinical science research appears to be predominantly
hypothesis-driven research to date. To appropriately
design and implement a clinical science research pro-
ject, therefore, there are several key components that
must be included.
Fig 1 shows the research project design process,
beginning with the development of a research question
and the corresponding hypothesis, the establishment of
a supporting conceptual framework for the hypothesis,
and testing the hypothesis.3 To test a hypothesis, the
variables that will be measured must be identified and
clearly described, the data capture plan must be out-
lined, and the data measurement integrity must be ver-
ified. From a perspective of determining measurement
integrity, a strategy to determine the validity (how
accurately the instruments used measure the constructs
that you are attempting to measure) and the reliability
(how reproducibly and stably your measurement
instrument performs) need to be established.
Next, options for possible study design approaches
need to be evaluated. In context of other project limita-
tions (such as feasibility, ethical considerations, or bud-
get constraints), the advantages and disadvantages of
each alternative study design approach need to be
assessed. At a minimum, the study method chosen
should adequately address the primary research ques-
tion of interest.
After the study design approach is selected, then the
data collection strategy (including a plan for the data
collection instrument design and testing) needs to be
developed. Correspondingly, both database program-
ming and data quality-control efforts need to be out-
lined. Within this study design context, the analysis
plan and corresponding sample size calculations need
to be coordinated.
From many years of experience, the key to success-
ful project planning is to assure the internal consisten-
cy among all aspects of the research project plan. The
study hypothesis, conceptual model linkages to exist-
ing theory and literature, study design approach select-
ed, analysis plan, and sample size calculations should
synchronize to clearly address the research question
posed. For example, the sample size approach used
should be based generally on the analytic approach
planned. Any inconsistencies within the research pro-
ject proposal should be clearly justified.
Often, a project budget must be developed. This bud-
get should be realistic, and potential sources of funding
must be identified. Depending on the possible funding
agency, a letter of intent may have to be submitted, fol-
lowed by a formal grant proposal. However, the specif-
ic format and content requirements of each funding
agency grants program may differ.
An administrative structure for the planned study
should also be established (ie, Who are the principal
investigator, co-investigator, consultants, and collabo-
rators? Who will participate in the study? Who will
administer the study on a day-to-day basis? Who will
collect the data and perform the planned analysis?) For
a clinical science project, ideally a multidisciplinary
team of clinicians, health services researchers, statisti-
cians, and other study support personnel (such as data-
base programmers, computer specialists, and others)
should be assembled, based on the project’s unique
needs. Thus a study implementation plan that carefully
identifies the roles and responsibilities of the study
team members is well advised.
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For most clinical science studies, the proposed study
should be reviewed and approved by the local
Institutional Review Board, according to their stan-
dards. Where appropriate, informed consent forms may
have to be obtained from the patient before entry into
the study. Additional study implementation concerns
relate to maintaining data confidentiality and security.
Access to study data should be limited to key personnel
where justified. Security precautions, such as password
protection and encryption of patient-specific identi-
fiers, should be planned. Confidentiality policies and
agreements should be established to protect study par-
ticipant privacy and to guard against unauthorized
access or use to the data captured. From an ethical
viewpoint, therefore, the research scientist is responsi-
ble for assuring the privacy, confidentiality, and securi-
ty of the study data maintained.
Finally, the need for a scientific monitoring review
committee should be assessed on the basis of the nature
and scope of the clinical science study. This type of
independent research project audit structure provides
for a preliminary review of the study data at interim
time points, to determine whether there is a need to
stop the study prematurely. Possible reasons for early
study closure include (but are not limited to) patient
safety issues (such as unanticipated adverse reactions)
or because of a superior effect being demonstrated
early in 1 of the study arms. This type of external sci-
entific review process, moreover, engenders public
confidence and trust that clinical science projects are
conducted appropriately.
Inherent to the design and implementation of a clinical
science research project, therefore, is the need for over-
all consistency and synergy between these key study
components. In any clinical science study, the success of
the project will relate to the integration and successful
completion of these critical study design components, as
the building blocks in the project’s foundation.
Terminology
In research, there are several basic concepts and def-
initions (both individual terms and the interrelation-
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Fig 1. Research project design process. The first step is to develop a research question and a corresponding
hypothesis, then to create the supporting conceptual framework for that hypothesis, and to provide the means by
which to test the hypothesis. The research method must be chosen; the population and sampling strategy must be
identified; the event must be observed; and the data must be captured, processed, and analyzed. (Adapted from
Babbie E. The practice of social research. 4th edition. Belmont [CA]: Wadsworth; 1986. Reprinted with permis-
sion of Wadsworth, a division of Thomson Learning. Fax 800 730-2215.)
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ships between these concepts) that one should under-
stand.3 The first concept is related to the scientific term
hypothesis. A hypothesis is a formal and testable state-
ment of relationships between dependent and indepen-
dent variables. The dependent variable is the study out-
come of interest. Clinical science research studies may
evaluate clinical outcomes, cost-effectiveness of care,
access to care issues, efficacy and effectiveness of new
therapies, patient preferences, and patient choices. For
example, the project’s dependent variable may be mor-
tality rates, morbidity rates, patient self-reported
health-related quality of life scores (such as the SF-36
physical or mental summary component scores),
patient satisfaction ratings, or patient utility scores. All
of these examples of dependent variables relate to the
possible outcomes that may be influenced by a health
care intervention (such as a diagnostic test, treatment,
operation) or episode of care (such as an emergency
room visit). The independent variables are other vari-
ables of interest that may have an association with the
dependent variable of study (including the intervention
of study).
For research purposes, null hypotheses and alterna-
tive hypotheses are often identified. A null hypothesis
normally states the lack of an association (or a random
association) between the dependent and independent
variables of study. An alternative hypothesis is usually
the association of interest with an identified direction
for the association, where appropriate. For example, a
clinical science project may examine the impact of a
surgical technique (such as off-pump cardiac bypass
procedures as the independent variable of primary
interest) on 30-day operative mortality rates (as the
dependent variable studied). In this example, the null
hypothesis might be stated, “There is no association
between off-pump bypass procedure approach (as com-
pared with a traditional surgical approach) and risk-
adjusted 30-day operative death rates.” In contrast, the
alternative hypothesis might be stated, “There is a rela-
tionship between the use of off-pump bypass proce-
dures and increased risk-adjusted 30-day operative
death rates.” To appropriately address other patient-
specific risk factors (as other independent variables that
may also potentially influence outcomes), a risk-adjust-
ment process with multivariate logistic regression mod-
eling is often used. Thus the impact of off-bypass pro-
cedures may be examined on operative mortality rates,
holding all other patient risk factors constant.
The second key concept to define is what is a fact. A
fact is an observation that may be repeated by either the
same observer or multiple observers to give the same
result. For example, a relevant fact may be the cardiac
surgery patient’s age that may influence the patient’s
risk of adverse events.
The next concept is a law. A law is a generalization
about a class of facts. Laws often are related to a well-
established set of principles by summarizing patterns in
scientific findings. For example, it has been well estab-
lished in the cardiac surgery field that as patient age
increases, the risk of adverse events increases also.
Theory, in contrast, is a systematic explanation of a
set of facts and laws. For predictions of risk in cardiac
surgery, Jones and colleagues4 have assimilated find-
ings from multiple national databases to identify a set
of consistent “core” risk factors that may influence
risk-adjusted outcomes of care. These risk factors
include acuity, previous heart surgery, age, ejection
fraction, sex, number of diseased vessels, and the pres-
ence of left main disease. To be consistent with the
theory in this field, therefore, new clinical research
studies that were were developed to predict risk of
death in cardiac surgery often incorporate these core
variables.
Finally, there is the concept of a paradigm, which is
a model or scheme that organizes our world view and
simplifies our understanding of reality. For example,
the paradigm of continuous quality improvement
places a value on provider self-assessment and self-
improvement. In this context, risk-adjusted outcomes
may be used to facilitate changes to improve quality of
care. Reporting risk-adjusted outcomes is not an end
unto itself but rather a means to an end. A primary goal
of clinical science research, therefore, is to use hypoth-
esis-driven research to document facts that may alter
the laws and theories that are developed, which may
subsequently redefine our paradigm of how to improve
the quality of medical care in the future.
Common study design approaches
From a research methods viewpoint, both clinical
investigation and health services research studies com-
monly use certain study design approaches. These
approaches include (but are not limited to) (1) scientif-
ic experimental approaches, (2) quasi-experimental
methods, and (3) observational clinical outcome stud-
ies. Although these methods are not unique to the field
of clinical science, it is important to understand the
strengths and weaknesses of each approach to answer
clinical science research questions.
Fig 2 shows the scientific experimental study design,
where subjects are randomized to either the interven-
tion or control group.5 In this approach, the outcomes
and covariates are measured in both groups at baseline.
After the administration of an experimental stimulus
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(the intervention of interest), the outcomes are remea-
sured in both the experimental and control group.
Given that clinical science studies are conducted on
human subjects and specimens, it may not always be
possible to control the experimental environment, the
intervention, and all possible other factors that may
influence the outcomes studied. This type of study is
often called a randomized, controlled clinical trial.
Although this study design represents the most rigor-
ous approach possible, it may not always be feasible or
possible to conduct this type of a research study,
because randomization may not be feasible. Moreover,
this type of experimental approach may not reflect real-
life clinical situations.
A second preference is a variety of quasi-experimen-
tal approaches. If subjects are not randomized, then it
may be possible to develop a set of comparison and
intervention groups, which are similar, based on a
matching process. Fig 3 shows the similarity of a quasi-
experimental approach to a traditional experimental
study design. Although not as rigorous as a random-
ized, controlled clinical trial, this type of approach may
often be used to answer important clinical questions.
For both experimental and quasi-experimental stud-
ies, the allowance for crossovers from 1 arm of the
study to another arm (as well as predefined criteria for
study failures) need to be addressed. The usual
approach, however, is to analyze the data conservative-
ly, according to the intention to treat (ie, according to
the original arm in which they were placed). An exam-
ple of this might be an angioplasty versus coronary
bypass intervention study, where a patient may have
been originally assigned to angioplasty. Given changes
in the patient’s clinical condition (according to pre-
specified criteria), however, the patient is crossed-over
to coronary artery bypass. This patient, however, would
normally be analyzed as receiving an angioplasty
rather than a bypass procedure.
If an intervention-based trial is not reasonable to pur-
sue, then observational studies are used to explore
associations between exposure to a given intervention
(or episode of care) with an outcome of interest. For a
given predefined patient population, possible study
design approaches include case-control studies (where
subjects are selected on the basis of the presence/
absence of the outcome of interest) or cohort studies
(where subjects are selected on the basis of exposure or
nonexposure to the intervention of interest).5 These tra-
ditional epidemiologic approaches to study design,
however, are limited because they cannot be used to
demonstrate causality.
For many observational studies, it may be possible to
use secondary source data (data collected for purposes
other than the research project) as an unobtrusive
approach to answer key clinical science questions.
Other possible observational study approaches include
meta-analysis (a systematic technique for analyzing a
set of studies), content analysis (a review of data to
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Fig 2. Experimental approach. A scientific experimental design is shown where subjects are randomized to either
an intervention or a controlled group, and the dependent variables and covariants, which are measured at baseline
in either an experimental stimulant or a placebo (control group), are administered. The dependent variable is
remeasured to assess the effect of experimental stimulus. (Adapted from Babbie E. The practice of social
research. 4th edition. Belmont [CA]: Wadsworth; 1986. p. 184. Reprinted with permission of Wadsworth, a divi-
sion of Thomson Learning. Fax 800 730-2215.)
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examine for patterns and to develop hypotheses about
possible relationships between variables), and analysis
of existing summary statistics (such as United States
census data) to evaluate for trends or to make compar-
isons across groups. These different types of study
approaches may be relatively inexpensive and timely
and may perhaps facilitate the addressing of questions
that may be normally beyond the data-capture abilities
of an individual investigator.
Analysis of secondary source data may be used to
find patterns and associations that might otherwise not
be explored. However, there are possible disadvantages
to these types of studies that use secondary source data.
First, because the data was captured for purposes other
than the research question of interest, not all of the key
data elements that should ideally be present for analy-
sis may actually be available. Second, the researcher is
at the mercy of the agency (as well as agency politics)
that controls the access to the data and is dependent on
the completeness and quality of the data available.
Finally, the conclusions drawn from the study findings
need to be thoughtfully placed in context of any known
assumptions (and possibly unknown factors) that may
have influenced the study’s results.
Studies may be designed as either cross-sectional
(based on observation assessed at a single point in time)
or longitudinal (based on observations made at multiple
time points). Although the possible study design
approaches to be used (and subtle permutations on
these approaches) are beyond the scope of this article,
these 3 approaches (experimental, quasi-experimental,
and observational studies) are common strategies used
in the field of clinical science.
Threats to study validity
Clinical science research presents many challenges.
When organizing a study, one has to guard against
threats to both external and internal validity. External
validity relates to the generalizability of the study’s
population. For example, to what degree is the patient
population enrolled or observed representative of the
general population of patients with the disease of inter-
est? Concerns of external validity may limit the appli-
cation of a given study’s conclusions to other popula-
tions or care settings.
Maximizing internal validity relates to minimizing
systematic bias. Possible areas of concern where bias
may commonly arise include (1) an enrollment bias
(that the patients who are enrolled are different in some
important way from those patients who did not enroll),
(2) a follow-up bias (that the patients for whom follow-
up data were procured are different in some important
way than those patients who were lost to follow-up), or
(3) a compliance bias (that the patients who complied
with the intervention/treatment regimen are different in
some important way than those patients who did not).
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Fig 3. Quasi-experimental approach. In a quasi-experimental approach, the subjects are not randomized; instead,
a comparison group is developed. The comparison group includes cases that are similar. Where appropriate, a
matching process may be used. Although not as rigorous as a randomized, controlled clinical trial, this type of
approach can be useful to answer important clinical questions. (Adapted from Babbie E. The practice of social
research. 4th edition. Belmont [CA]: Wadsworth; 1986. p. 184. Reprinted with permission of Wadsworth, a divi-
sion of Thomson Learning. Fax 800 730-2215.)
Image available in print version only
Systematic bias may completely invalidate a study’s
findings.
External influences that may potentially bias the
study’s results should also be carefully considered.
Where possible, these external influences should be
measured as study covariates. Unmeasured influences
represent possible confounding variables. Examples of
possible external influences include contamination
between the study groups, where the control and inter-
vention arms may exchange information or compare
treatment regimen results informally. Key issues may
arise that are related to the knowledge of the identity of
study and control group assignment. Thus a single-blind-
ed approach (where either the subject or the researcher
does not know the study arm assigned) or double-blind-
ed approach (where neither the subject or the researcher
knows the arm assignment) may be used to proactively
prevent this type of problem from occurring.
Another issue of concern in clinical science research
is that, during the course of a study, changes in clinical
practice can take place that could affect the outcome of
the study. An example of this would be technologic
improvements that yield progressively better results
during the course of the study, rendering the first part
of the study irrelevant and/or outdated. Thus a time-
dependent association with the outcome of interest may
be present.
Sample size issues
Ethically, it is important not to study too many sub-
jects or too few subjects, because both of these
approaches may be wasteful or detrimental (either
directly to patients or to the future knowledge base in
this field). Thus it is important to determine the sample
size (an estimate of the number of subjects needed) as
part of the study design process.
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Fig 4. Incidence of the use of the internal mammary artery (IMA) in first-time CABG procedures in the STS data-
base. Note that, from 1990 to 1997, there has been a marked increase in the use of at least 1 internal mammary
artery in coronary bypass procedures, increasing from 48.45% to 79.77%. Data such as this from observational
databases can serve as benchmark comparisons for practicing clinicians. (From data analysis of The Society of
Thoracic Surgeons National Adult Cardiac Surgery Database, The Eight Year, December 1998.)
An adequate sample size addresses a common human
fallacy: to overgeneralize inappropriately on the basis
of the results found for a few cases. Moreover, an ade-
quate sample size minimizes the possibility of a type II
(β) statistical error. For reference, a type II error is a
false negative (that is, the null hypothesis is actually
false, but it has not been disproved appropriately). With
a larger sample size (which correspondingly increases
statistical power), however, a statistical difference
might have been detected to disprove the study’s null
hypothesis.
As a direct result of sample size calculations, it may
be self-evident that adequate accrual to the planned
clinical project will require a multicenter study.
Multicenter studies present additional study design and
implementation challenges. The key factor for success
of a multicenter study is the use of a uniform and stan-
dardized protocol. Common concerns in multicenter
studies include possible interrater variability in data
capture, institutional variability in protocol administra-
tion/adherence, the diverse levels of dedication to the
study by the key participating investigators, the contin-
ued accrual of patients, and communication issues with
the central study leadership team.
Research funding opportunities
Numerous funding options are available for clinical
science studies. Although there are exceptions, howev-
er, most grant opportunities require that the principal
investigator hold a doctoral-level degree.
Grant funding may be available through local, state,
regional, or national opportunities. Commonly, several
national organizations fund clinical science research
projects. For individuals interested in research ques-
tions that are related to cardiothoracic research topics,
these organizations may include the National Institutes
of Health, the Agency for Health Care Policy and
Research, the Department of Veterans Affairs (both
Health Services Research and Cooperative Studies
Programs and the Clinical Merit Review Programs), the
Health Care Financing Agency, the American Heart
Association, the American College of Surgeons, phar-
maceutical and device industries, foundations (such as
the Thoracic Surgery Foundation for Research and
Education), and trauma organizations, as well as many
other sources. The possibilities for funding should be
investigated carefully to determine a match between the
agency’s funding goals and the planned objectives of
the research project.
Clinical science studies
Several examples of clinical science research projects
will be reviewed, beginning with single-center studies.
An example of a retrospective, observational study is
entitled, “Single Lung Transplantation: Alternative
Indications and Technique.”6 This article by Calhoon
and colleagues hypothesized that a telescoping
bronchial anastomosis without omental wrap was as
efficacious as the use of a more complicated technique.
This retrospective review of 22 patients (who had
undergone 23 single lung transplantations) was per-
formed at a single site. It had no control group, using a
historic comparison based on the available literature.
The results demonstrated that this technique was com-
parable to the previously published literature for mor-
tality rate and rate of perioperative complications. This
article’s conclusion, therefore, was to use the more sim-
ple technique because the results were as good.
Another classic example of a retrospective observa-
tional study is the study by Loop and colleagues7 enti-
tled, “Influence of the Internal Mammary Artery Graft
on 10-year Survival and Other Cardiac Events.” This
single-center, retrospective cohort study compared 10-
year actuarial survival rates between 2 groups. The
intervention group of interest involved the use of an
internal mammary artery to the left anterior descending
coronary artery in comparison with the group of
patients with only saphenous vein graft procedures.
Both groups of patients that were reviewed underwent
operation during a comparable time period. The patient
outcomes that were evaluated included the actuarial
survival, incidence of myocardial infarction, rehospi-
talization, cardiac reoperation, and late cardiac events.
The article’s conclusion was that the internal mamma-
ry artery conduit was preferable when feasible, because
the results appeared to be superior.
An alternative common type of single-center study
published is a prospective, double-blinded, randomized
controlled clinical trial. These studies are planned and
submitted before the study to a local Institutional
Review Board with a set protocol, sample size projec-
tion, and a plan for statistical analysis. One example is
a study reported in 1977 entitled, “Prophylactic
Antibiotics in the Treatment of Penetrating Chest
Wounds: A Prospective Double Blind Study.”8 In this
study the hypothesis was that antibiotics would reduce
infection and sepsis in penetrating chest trauma. The
study inclusion population was confined to those
patients with penetrating chest trauma. Patients were
randomized to 2 groups, those receiving antibiotics and
those receiving a placebo. The outcomes measured
were death, temperature, white blood cell count, cul-
ture data, evidence of wound sepsis, radiograph evi-
dence for pneumonia or effusion, emphysema, and
operative interventions. The conclusion of the study
was that prophylactic antibiotics decreased pneumonia,
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the incidence of fever, emphysema, wound infection,
operations, and length of hospital stay. This was a fair-
ly simple study that had (as many single-center studies
often have) a borderline sample size. Additionally, it is
possible that a single-center bias may exist that is relat-
ed to the other processes of care that may have influ-
enced the outcomes of study.
The next example of a single-center prospective
analysis by Fullerton and colleagues9 is entitled,
“Effective Control of Pulmonary Vascular Resistance
with Inhaled Nitric Oxide after Cardiac Operation.”
This study tested the hypothesis that nitric oxide would
selectively decrease pulmonary vascular resistance in
patients after cardiopulmonary bypass. Twenty patients
received nitric oxide. Given that assessments of out-
come were performed both before, during, and after
nitric oxide administration, these patients served as
their own controls. The outcome variables measured
were pulmonary artery pressure, pulmonary vascular
resistance, systemic vascular resistance, and arterial
blood pressure. It was concluded that pulmonary vas-
cular resistance was selectively decreased by nitric
oxide in this group of patients.
These 3 clinical science research projects are there-
fore examples of relatively straightforward, simple
studies that can be done by most clinicians at a single
center to answer clinically important and pragmatic
questions.
When a greater sample size is required and the poten-
tial biases of a single center need to be minimized, a
multicenter study should be considered. In general,
most multicenter studies are prospective, although it is,
of course, possible to pool data from multiple institu-
tions for retrospective analyses. Almost always, how-
ever, a more powerful and convincing study is a
prospective randomized controlled clinical trial with
pre-established criteria for patient inclusion, standard-
ized protocol administration, and uniform outcome
analysis.
Two examples of prospective multicenter scientific
studies are the Coronary Artery Surgery Study (CASS)
Study10 and the Veterans Affairs Aspirin Study that
related to coronary bypass grafting patients.11 CASS
was a randomized trial of coronary artery bypass
surgery that studied survival data as an outcome. It was
multicentered with a prospective patient registry and a
controlled clinical trial between coronary bypass and
medical treatment in patients with Canadian Cardio-
vascular Society Class 1 and 2 angina. The CASS
hypothesis was that the coronary artery bypass graft
(CABG) procedure would decrease death and ischemic
events in patients with coronary artery disease as com-
pared with medical treatment. The CASS registry
included 16,626 patients. However, only 2099 patients
were eligible for randomization, and of that number,
only 780 patients were randomized. Of those patients
assigned to medical therapy, 24% of the patients were
crossed over to surgery but were analyzed as if they
were treated medically. This is an example of the diffi-
culties that are encountered when very complex multi-
center perspective studies are designed with the best
intentions, in that a very small proportion of eligible
patients were actually randomized for study.
The findings were that there was no significant dif-
ference in mortality rates between groups. The conclu-
sion was that excellent survival rates occurred in both
groups, which supported delaying CABG until more
symptoms developed. That conclusion may well be a
real and relevant one, but critics could argue that a large
number of patients were excluded, limiting the study’s
generalizability. Entrance criteria based only on class 1
and 2 symptom levels was so narrowly defined that it
would be improbable that indeed there would be a sur-
vival benefit of 1 therapy over the other. Nevertheless,
it probably did serve to answer questions in that select
group of patients.
The next example is a study by Goldman and col-
leagues11 on the effects of aspirin when given beyond 1
year after operation in patients who have undergone
CABG. This was a multicenter Veterans Affairs coop-
erative study in which the hypothesis was that aspirin
would increase patency. It was prospective, double-
blinded in approach and compared groups receiving
aspirin therapy with groups receiving placebo. The end
points were angiography at 3 years. Conclusions were
that aspirin probably does not improve patency when
given beyond 1 year after CABG. This was a study that
had a high percentage of follow-up with a gold stan-
dard for measurement of coronary patency (ie, coro-
nary angiography at 3 years). Again, this answered a
very specific, simple, pragmatic clinical question.
The next category of clinical studies is clinical out-
comes of observational studies that fall within the
health services research area. Examples of this type of
study are related to analyses conducted with the use of
pre-established databases. Databases used for this pur-
pose include the Society of Thoracic Surgeons (STS)
National Cardiac Surgery Database, the Department of
Veterans Affairs Continuous Quality Improvement in
Cardiac Surgery Program Database, the Northern New
England Cardiovascular Database, the New York State
Database, and single institution large databases, such
as the Duke Database. Many of these well-established,
large databases include data on patient risk characteris-
tics, procedural details, and outcomes of care after sur-
gical procedures.
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Descriptive analyses (to document patient character-
istics and procedure usage) can be performed to under-
stand variations in patterns of practice. For example,
the STS database had approximately 450 participating
member sites from across the United States that report-
ed 1,074,689 procedures in the period from 1990 to
1997.12 During this same time, the operative mortality
rate for CABG procedures fell from 4.59% (1990) to
2.54% (1997). Annual use of the internal mammary
artery for first-time CABG procedures increased from
48.45% (1990) to 79.77% (1997) (Fig 4). Moreover,
the reported median postoperative length of hospital
stay dropped for first operation, elective CABG proce-
dures decreased from 8 days (1990) to 5 days (1997).
With the use of statistical analysis techniques, risk-
adjusted outcomes of care and resource usage measures
can be reported both in patient subpopulations and in
aggregate. For example, the mean postoperative length
of hospital stay reported by clinical groupings for risk-
adjusted operative death rates in the 1995 to 1996 STS
database were (1) very low-risk grouping (0%-2.5%
predicted risk), 8.4 days; (2) low-risk grouping (>2.5%-
5.0% predicted risk), 11.9 days; (3) intermediate-risk
grouping (>5.0%-10.0% predicted risk), 12.8 days; (4)
moderate-risk grouping (>10%-20% predicted risk),
14.8 days; (5) high-risk grouping (>20%-30% predict-
ed risk), 16.1 days; and (6) very high-risk grouping
(>30.0% predicted risk), 17.2 days. Moreover, these
STS summary data are publicly available on the web
site (www.sts.org). Thus this data may be very useful
for hospitals or surgical group practices to use as
benchmarks and as historic reference information for
research purposes.
Recently, a new mechanism to access the STS
National Adult Cardiac Database has been made avail-
able through mechanisms listed on the STS web site.
An open invitation to cardiac surgeons with an interest
in health services research has been made to explore
key research issues with the use of this database.13 Thus
requests for special research project analyses are now
being accepted.
These databases can be analyzed for various outcome
studies. Examples of the use of these databases include
studies on the effect of the use of the internal mamma-
ry artery on 30-day mortality rates from the STS
Database by Crawford and colleagues14 and by Grover
and colleagues15 who used the Veterans Affairs
Continuous Quality Improvement in Cardiac Surgery
Program; the effect of gender on outcomes by Edwards
and colleagues16 from the STS; the effects of volume
on mortality rates from both the Veterans Affairs
Continuous Quality Improvement in Cardiac Surgery
Program and STS databases;17,18 and an examination of
variations in outcomes between institutions from the
Northern New England database.19 In the Northern
New England database efforts, a further exploration of
these variations led to their ongoing quality improve-
ment program in which best practices are shared
between hospitals and surgeons to improve the quality
of patient care.
Fundamentally, observational studies that use sec-
ondary source data (such as these databases) provides
an opportunity to conduct studies that would not other-
wise be feasible to the individual investigator. Primary
clinical science research project constraints that use
secondary source data, however, may be related to data
integrity (both completeness and quality) and to the
fact that the research questions must be limited to the
data available.
In addition, there are various clinical science research
studies that are conducted prospectively, such as the
study by Shroyer and colleagues20 that was funded by
the Department of Veterans Affairs entitled, “The
Processes, Structures, and Outcomes of Care in
Cardiac Surgery Study Protocol.” This study gathered a
comprehensive set of patient risk factors, processes of
care, structures of care, and outcomes for approximate-
ly 5000 patients who underwent a cardiac surgery pro-
cedure at 14 participating Veterans Affairs medical cen-
ters. An example of how a data set such as this can be
used for a substudy analysis was recently published by
Almassi and colleagues,21 whose objective was to
investigate the incidence, the predictors, and the mor-
tality rates associated with atrial fibrillation and its
impact on length of stay. The Processes, Structures, and
Outcomes of Care in Cardiac Surgery study population
was 3855 patients who had undergone CABG-only
procedures performed at 14 Veterans Affairs hospitals.
The primary study outcome of atrial fibrillation was
found in 1500 patients. The findings of Almassi and
colleagues were that there were multiple predictors of
atrial fibrillation and that this key complication
increased overall patient mortality rates and length of
hospital stay.
Recently, the Department of Veterans Affairs institut-
ed a major clinical science research focus to monitor
guideline compliance headed by John Feussner, MD,
Chief of Research Services, and by John Demakis,
MD, Head of Clinical Outcomes Studies. This national
initiative is entitled, “Quality Enhancement Research
Initiative: QUERI.” A variety of different research
endeavors, including many new research studies relat-
ed to ischemic heart disease, are ongoing as a part of
this new initiative.
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As evidenced by the literature reference used earlier,
health services research studies are fertile ground for car-
diothoracic surgical investigators because they measure
pragmatic issues that involve quality of care, access to
care, and cost of care, all of which are issues that are
exceedingly important in the current health care environ-
ment. Also, one does not have to have advanced academ-
ic training in either molecular biology or genetics to suc-
cessfully perform these studies. Health services research,
however, requires a multidisciplinary approach. Thus
clinicians who are partnering with research scientists
(with expertise in clinical research approaches and out-
comes analysis) and biostatisticians (for the more com-
plex statistical analyses of large population databases) are
extraordinarily important.
Summary
The examples given earlier serve to support the value
of clinical science research, as research options avail-
able to both inexperienced and experienced investiga-
tors alike. As described, these diverse studies span the
realm of the inexpensive, single-center, retrospective
studies to rather expensive, multicenter, prospective
studies. They are, however, studies that should have
appeal to clinical cardiothoracic surgeons because the
data are obtained from the clinical arena. Designing
these studies requires a scientific discipline, dedicated
planning time to develop hypotheses and methods, and
collaborative efforts with clinical research specialists,
health care researchers, and statisticians. In so doing,
the understanding of cardiothoracic patient care can be
expanded and the quality of future patient care can be
improved.
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